Board of Trustees: Previous

AM is a Group Leader, in vivo pharmacology, and the Cardiovascular Therapeutic Area Lead at Evotec (UK) Ltd. Her work has focused on the prevention and treatment of chronic diseases across the lifespan, in particular cardiovascular, metabolic, and inflammatory diseases. Dr Spiroski currently supports the development of therapeutic candidates, including novel advanced therapy medicinal products (ATMPs),

Adrian is the founder of the Live Forever Club providing scientific research-based information on ageing and longevity to a wide non-academic audience. He is also an experienced IT business analyst in the medical and pharmaceutical industries. View Adrian’s trustee profile.